Henlius Achieved Steep Revenue Growth in Q1 2023, Core Products Sales Surged
/PRNewswire/ -- As a global innovative biopharmaceutical company, Henlius is committed to offering high-quality, affordable and innovative biopharmaceuticals...
Source: prnewswire.com